Measures antibodies against 7 groups of proteins and peptides associated with the development of Alzheimer’s disease and other neurodegenerative disorders: brain proteins; growth factors; enteric nerve, enzymes, and neurological peptides; pathogens; chemicals; foods cross-reactive to amyloid-beta; and blood-brain barrier and neurofilaments. Detects Alzheimer's-associated immune reactivity. It helps identify patients at a greater risk of developing Alzheimer's disease or other neurological disorders, identify the early stage of neurodegenerative processes, and monitor the effectiveness of lifestyle modifications for Alzheimer's disease. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2015, 2018 and 2021.
Hey Practitioners! 
On December 11th, join Dr. Terry Wahls in a free live class where she'll share her groundbreaking methods for managing MS and autoimmune patients. This live session will address your most pressing questions and will take a closer look at treatment options beyond the conventional standards of care. Register here.
Register Here
.svg){kind=small}
.svg){kind=small}
